Today’s action potentials

what we are reading
“NSF tests ways to improve research security without disrupting peer review”
By Jeffrey Mervis in Science
Read more
Quote

Of course, there are still several hurdles to cross until such a treatment approach shows safety and efficacy in a clinical trial. Nonetheless, it’s an exciting beginning based on rigorous basic neurobiology. — MUSTAFA SAHIN

Read more
Image
VOLUNTEER OPPORTUNITY
OCTOBER
18-20
2024
Join an organizing committee for the Diversity and Equity Initiative (DivE In) weekend
Learn more
Spectrum logo
Black-and-white photograph of William Catterall in a lab.

The legacy of William Catterall, ‘father of ion channels’

By Calli McMurray
12 March 2024 | 7 min read
See all Profiles See all Profiles - opens a new tab
Close-up of a green glass slide embedded with dozens of tiny electrodes.

Making cancer nervous

Nerve cells in the brain and throughout the body can turbocharge tumor growth — a finding that not only expands conventional ideas about the nervous system but points to novel therapeutic targets for a range of malignancies.

By Sarah DeWeerdt
13 November 2023 | 22 min read
Photograph of a gloved hand pointing to a computer screen that is displaying an image of a mouse brain.

Uncertainty and excitement surround one company’s cell therapy for epilepsy

After 10 years of work, Neurona may have the data to quiet its skeptics. But its ongoing clinical trial will be the ultimate test.

By Angie Voyles Askham
5 October 2023 | 19 min read
See all Features See all Features - opens a new tab

Sign up for The Transmitter newsletters

Our biggest stories, delivered to your inbox every day.